IKT vs AAPL: Which Stock is Better?
Side-by-side comparison of Inhibikase Therapeutics Inc and Apple Inc in 2026
IKT
Inhibikase Therapeutics Inc
$1.78
AAPL
Apple Inc
$258.74
Key Metrics Comparison
| Metric | IKT | AAPL | Winner |
|---|---|---|---|
| Market Cap | $225.78M | N/A | IKT |
| P/E Ratio | N/A | 32.80 | AAPL |
| EPS (TTM) | $N/A | $7.89 | AAPL |
| Revenue Growth | -1.0% | 0.2% | AAPL |
| Gross Margin | -3062780800.0% | 47.3% | AAPL |
Analyze IKT
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IKT or AAPL a better investment?
Comparing IKT and AAPL: Inhibikase Therapeutics Inc has a market cap of $225.78M while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IKT and AAPL?
IKT (Inhibikase Therapeutics Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IKT or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IKT or AAPL?
AAPL has higher revenue growth at 0.2% vs -1.0% for IKT.
Which company is more profitable: IKT or AAPL?
Apple Inc (AAPL) has higher gross margins at 47.3% compared to -3062780800.0% for IKT.
Which is the larger company: IKT or AAPL?
Inhibikase Therapeutics Inc (IKT) is larger with a market cap of $225.78M compared to N/A for AAPL.
Should I buy IKT or AAPL in 2026?
Both IKT and AAPL have investment merit. IKT trades at $1.78 while AAPL trades at $258.74. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IKT and AAPL stock?
Key differences: Market Cap ($225.78M vs N/A), P/E Ratio (N/A vs 32.8x), Revenue Growth (-1.0% vs 0.2%), Gross Margin (-3062780800.0% vs 47.3%).